1. Large study provides little evidence of ARB-cancer link

   Clinical study 12 January 2013 Pages: 1 - 1

2. CSL Biotherapies Australia is taking extra steps to ensure the safe use of Fluvax [influenza virus vaccine] in young children.

   Media release 12 January 2013 Pages: 2 - 2

3. FDA enhances oversight of postmarket drug safety

   Media release 12 January 2013 Pages: 2 - 2

4. The EMA’s Pharmacovigilance Working Party (PhVWP) has concluded a review into the safety of blue dyes,

   News item 12 January 2013 Pages: 2 - 2

5. The US FDA is recommending against co-administration of boceprevir [Victrelis] and certain ritonavir-boosted HIV protease inhibitors.

   News item 12 January 2013 Pages: 2 - 2

6. Misclassification markedly affects estimates of ADR risk

   Epidemiology population study 12 January 2013 Pages: 3 - 3

7. Incidence, cost of neonatal abstinence syndrome increasing

   Clinical study 12 January 2013 Pages: 3 - 3

8. News from the 8th European Breast Cancer Conference

   Meeting report 12 January 2013 Pages: 4 - 4

9. Adalimumab/etanercept/infliximab

   Case report 12 January 2013 Pages: 6 - 6

10. Adalimumab/etanercept

    Case report 12 January 2013 Pages: 6 - 6

11. Adalimumab

    Case report 12 January 2013 Pages: 6 - 6

12. β-lactams

    Case report 12 January 2013 Pages: 6 - 6

13. Adalimumab

    Case report 12 January 2013 Pages: 6 - 6

14. Adalimumab/etanercept/infliximab

    Case report 12 January 2013 Pages: 7 - 7

15. Adalimumab/leflunomide

    Case report 12 January 2013 Pages: 7 - 7

16. Amitriptyline/hydroxyzine overdose

    Case report 12 January 2013 Pages: 7 - 7

17. Alteplase

    Case report 12 January 2013 Pages: 7 - 7

18. Alendronic acid/ibandronic acid/risedronic acid

    Case report 12 January 2013 Pages: 7 - 7

19. Amlodipine

    Case report 12 January 2013 Pages: 8 - 8

20. Amphotericin B liposomal

    Case report 12 January 2013 Pages: 8 - 8

21. Amoxicillin

    Case report 12 January 2013 Pages: 8 - 8

22. Antineoplastics

    Case report 12 January 2013 Pages: 8 - 8

23. Analgesics

    Case report 12 January 2013 Pages: 8 - 8

24. Antithymocyte globulin/ciclosporin

    Case report 12 January 2013 Pages: 9 - 9

25. Antithymocyte globulin/ciclosporin

    Case report 12 January 2013 Pages: 9 - 9

26. Antineoplastics/pyridoxine

    Case report 12 January 2013 Pages: 9 - 9

27. Atorvastatin

    Case report 12 January 2013 Pages: 10 - 10

28. Arginine

    Case report 12 January 2013 Pages: 10 - 10

29. Aspirin

    Case report 12 January 2013 Pages: 10 - 10

30. Aspirin

    Case report 12 January 2013 Pages: 10 - 10

31. Botulinum toxin A

    Case report 12 January 2013 Pages: 11 - 11

32. Atorvastatin

    Case report 12 January 2013 Pages: 11 - 11

33. Bevacizumab

    Case report 12 January 2013 Pages: 11 - 11

34. Bupropion

    Case report 12 January 2013 Pages: 11 - 11

35. Bevacizumab

    Case report 12 January 2013 Pages: 11 - 11

36. Bevacizumab

    Case report 12 January 2013 Pages: 11 - 11

37. Cabazitaxel

    Case report 12 January 2013 Pages: 12 - 12

38. Capecitabine

    Case report 12 January 2013 Pages: 12 - 12

39. Carbamazepine/phenobarbital/phenytoin

    Case report 12 January 2013 Pages: 12 - 12

40. Capecitabine

    Case report 12 January 2013 Pages: 12 - 12

41. Cabergoline

    Case report 12 January 2013 Pages: 12 - 12

42. Cefotaxime

    Case report 12 January 2013 Pages: 13 - 13

43. Celecoxib

    Case report 12 January 2013 Pages: 13 - 13

44. Certolizumab pegol

    Case report 12 January 2013 Pages: 13 - 13

45. Citalopram

    Case report 12 January 2013 Pages: 14 - 14

46. Ciprofloxacin

    Case report 12 January 2013 Pages: 14 - 14

47. Ciprofloxacin

    Case report 12 January 2013 Pages: 14 - 14

48. Colchicine/various drugs interaction

    Case report 12 January 2013 Pages: 15 - 15

49. Clopidogrel

    Case report 12 January 2013 Pages: 15 - 15

50. Conjugated linoleic acid

    Case report 12 January 2013 Pages: 15 - 15